NYSE$RVTY
Revvity Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
PerkinElmer reported revenue of $964.0 million with 36% reported growth and 34% organic growth. GAAP EPS from continuing operations was $1.57 and adjusted EPS was $2.09.
PerkinElmer reported strong financial results for the third quarter of 2020, with significant revenue growth driven by the Diagnostics segment. The company's GAAP EPS and adjusted EPS also showed substantial increases compared to the same period last year, reflecting improved profitability.
- Revenue reached $964.0 million, demonstrating 36% reported growth and 34% organic growth.
- GAAP EPS from continuing operations was $1.57, up from $0.53 in Q3 2019.
- Adjusted EPS was $2.09, compared to $1.06 in Q3 2019.
- Operating income from continuing operations was $248.0 million, significantly higher than $78.7 million in the prior year.
Headline financials
Revenue & EPS history
Revvity · Revenue · Quarterly
$964M
Revenue by segment
Revvity · $540M total across 1 segment · Q3 2020
- Diagnostics$540M+93.0%100.0%
Forward guidance
The Company forecasts for the fourth quarter of 2020, GAAP revenue in the range of $1.12 billion to $1.23 billion, GAAP earnings per share from continuing operations of $2.27 to $2.67 and, on a non-GAAP basis, adjusted earnings per share of $2.60 to $3.00.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
-0.1%
Avg return
Earnings day
+0.3%
Avg return
5 days after
-0.0%
Avg return
30 days after
48%
31 / 64 earnings
Positive
+10.4%
Q2 2024
Best reaction
-16.3%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.5% | +17.0% | +16.7% | |
| Q4 2025 | -4.5% | -6.6% | -9.5% | |
| Q3 2025 | -1.8% | -5.4% | +5.8% | |
| Q2 2025 | +3.3% | +1.9% | -5.8% | |
| Q1 2025 | +0.8% | -0.3% | -3.1% | |
| Q4 2024 | -0.5% | -3.5% | -11.6% | |
| Q3 2024 | +4.1% | +1.2% | -4.1% | |
| Q2 2024 | +10.4% | +7.1% | +5.3% | |
| Q1 2024 | +0.9% | -0.9% | +8.1% | |
| Q4 2023 | -1.4% | -2.8% | -0.1% | |
| Q3 2023 | -16.3% | -9.9% | -8.6% | |
| Q2 2023 | +1.8% | +0.2% | -4.8% | |
| Q1 2023 | -6.6% | -8.3% | -10.8% | |
| Q4 2022 | -2.4% | -3.8% | -9.1% | |
| Q3 2022 | -2.3% | +11.0% | +9.9% | |
| Q2 2022 | +0.6% | +0.4% | -11.8% | |
| Q1 2022 | +6.2% | -0.0% | +2.0% | |
| Q4 2021 | +7.5% | +6.3% | +4.0% | |
| Q3 2021 | -1.3% | -4.3% | +2.1% | |
| Q2 2021 | +3.5% | +10.9% | +12.6% | |
| Q1 2021 | +4.6% | +8.0% | +6.2% | |
| Q4 2020 | -8.0% | -4.5% | -18.2% | |
| Q3 2020 | +1.3% | +4.4% | +1.7% | |
| Q2 2020 | +4.1% | +3.4% | -0.4% | |
| Q1 2020 | +7.2% | +6.3% | +18.4% | |
| Q4 2019 | -2.3% | -7.3% | -13.8% | |
| Q3 2019 | -2.3% | -0.4% | +5.6% | |
| Q2 2019 | -7.9% | -11.0% | -13.9% | |
| Q1 2019 | -0.5% | +1.4% | -8.6% | |
| Q4 2018 | +0.7% | +2.8% | +6.9% | |
| Q3 2018 | -4.5% | -3.1% | +1.6% | |
| Q2 2018 | +9.3% | +8.2% | +16.7% | |
| Q1 2018 | -2.2% | -1.7% | +0.4% | |
| Q4 2017 | +1.6% | -0.5% | -5.4% | |
| Q3 2017 | -2.3% | -1.6% | +1.2% | |
| Q2 2017 | -3.6% | -4.0% | +0.4% | |
| Q1 2017 | +3.3% | +4.9% | +8.8% | |
| Q4 2016 | -3.0% | -2.0% | +2.2% | |
| Q3 2016 | -2.1% | -1.9% | +2.3% | |
| Q2 2016 | -0.1% | -0.3% | +0.5% | |
| Q1 2016 | +1.0% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +4.3% | — | — | |
| Q1 2015 | +1.5% | — | — | |
| Q4 2014 | +2.7% | — | — | |
| Q3 2014 | +1.9% | — | — | |
| Q2 2014 | -5.5% | — | — | |
| Q1 2014 | -3.4% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q3 2013 | -1.7% | — | — | |
| Q2 2013 | +6.8% | — | — | |
| Q1 2013 | -10.6% | — | — | |
| Q4 2012 | -3.5% | — | — | |
| Q3 2012 | -1.0% | — | — | |
| Q2 2012 | +5.4% | — | — | |
| Q4 2008 | -0.5% | — | — | |
| Q1 2012 | +3.0% | — | — | |
| Q1 2011 | +0.2% | — | — | |
| Q4 2011 | +3.5% | — | — | |
| Q3 2009 | +1.4% | — | — | |
| Q3 2011 | +1.4% | — | — | |
| Q2 2009 | -3.1% | — | — | |
| Q2 2011 | -3.1% | — | — | |
| Q4 2010 | -3.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro